Lung Cancer Clinical Trial

This study compares two treatments for advanced lung neuroendocrine tumors (NETs): everolimus, the current standard, and Lutetium 177 Dotatate, a targeted radiation therapy. The study aims to find out if Lutetium works better at slowing or shrinking tumors that show uptake on a somatostatin receptor PET scan.